Physician profile
Mark E Granoff
NPI 1124058474
$1,652.06
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,242 · 2020: $323 · 2021: $87.32.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $443.23 | 2019-2020 | |
| Abbvie INC. | $272.91 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $122.14 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $119.57 | 2020 | |
| Amarin Pharma, INC. | $100.17 | 2019-2020 | |
| Lilly USA, LLC | $68.52 | 2019 | |
| Sanofi-Aventis U.S. LLC | $67.98 | 2019 | |
| Glaxosmithkline, LLC. | $63.29 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $48.21 | 2019 | |
| Janssen Biotech, INC. | $43.17 | 2019-2020 | |
| Mylan Specialty L.P. | $41.04 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $38.20 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $31.08 | 2019 | |
| Medtronic Vascular, INC. | $31.05 | 2019 | |
| Esperion Therapeutics, INC. | $28.71 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $25.54 | 2019 | |
| Novo Nordisk INC | $22.26 | 2019 | |
| Daiichi Sankyo INC. | $19.05 | 2019 | |
| Arbor Pharmaceuticals, INC. | $18.85 | 2019 | |
| Terumo Bct, INC. | $18.75 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.36 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $12.98 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Granoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.